Omaxe Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(d) and other ....
OMAXE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omaxe Ltd has informed BSE that its Board of Directors will meet on May 15, 2025, to consider raising funds in one or more tranches. The fund raising could be through equity shares, convertible securities, non-convertible securities, or any combination, via private placement, preferential allotment, rights issue, qualified institutions placement (QIP), or other permissible modes. The decision is subject to shareholder and regulatory approvals. The trading window for dealing in the company's shares remains closed from April 1, 2025, until 48 hours after the declaration of audited financial results for the quarter and financial year ending March 31, 2025.
The filing signals that Omaxe may dilute existing shareholders through a potential equity or convertible securities issuance. The exact mode, size, and pricing are not disclosed yet, so the market will await the Board meeting outcome on May 15, 2025, for clarity on dilution risk and capital structure impact.